Schedule 13G ownership disclosure

ProQR Therapeutics NV

Security class unavailable · CUSIP: N71542109

Event date: 2018-03-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-18-023745
Form type
SC 13G
Filer
Aescap Medical Investments B.V.
CIK
CIK 1737276
Filed
Apr 12, 2018
Reporting period
Mar 27, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub